Is there a relationship between mean blood glucose and glycated hemoglobin?

Journal of Diabetes Science and Technology

Volumn 5, Issue 6, 2011, Pages 1572-1583

  Makris, Konstantinos ^a   Spanou, Loukia ^a  

^a KAT HOSPITAL   (Greece)

Author keywords

Diabetes; Estimated average glucose; Glucose; Glycated hemoglobin; Hemoglobin A1c; Mean blood glucose; Mean plasma glucoset

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

BLOOD; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; METABOLISM; REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 84862705232     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681100500634     Document Type: Review

References (123)

1. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328(23):1676-85. (Pubitemid 23157351)
2. Kilpatrick ES. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol. 2008;61(9):977-82.
3. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia: a molecular disease. Science. 1949;110(2865):543-8.
4. Kunkel HG, Wallenius G. New hemoglobin in normal adult blood. Science. 1955;122(3163):288.
5. Allen DW, Schroeder WA, Balog J. Observations on the chromatographic heterogeneity of normal adult and fetal human hemoglobin: a study of the effects of crystallization and chromatography on the heterogeneity and isoleucine content. J Am Chem Soc. 1958;80(7):1628-34.
6. Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun. 1969;36(5):838-43.
7. Rahbar S. An abnormal hemoglobin in red cells of diabetics. Clin Chim Acta. 1968;22(2):296-8.
8. Schnek A, Schroeder W. The relation between the minor components of whole normal human adult hemoglobin as isolated by chromatography and starch block electrophoresis. J Am Chem Soc. 1961;83:1472-8.
9. Brownlee M. Negative consequences of glycation. Metabolism. 2000;49(2 Suppl 1):9-13. (Pubitemid 30091786)
10. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, Baynes JW, Lyons TJ. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest. 1993;91(6):2470-8. (Pubitemid 23182498)
11. Thorpe SR, Baynes JW. Role of the Maillard reaction in diabetes mellitus and diseases of aging. Drugs Aging. 1996;9(2):69-77. (Pubitemid 26261743)
12. Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin Chem. 1986;32(10 Suppl):B37-41.
13. Brownlee M, Cerami A, Vlassara H. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic vascular disease. Diabetes Metab Rev. 1988;4(5):437-51.
14. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci U S A. 1992;89(24):12043-7. (Pubitemid 23004781)
15. McDonald MJ, Shapiro R, Bleichman M, Solway J, Bunn HF. Glycosylated minor components of human adult hemoglobin. Purification, identification, and partial structural analysis. J Biol Chem. 1978;253(7):2327-32. (Pubitemid 8328218)
16. Hoelzel W, Miedema K. Development of a reference system for the international standardization of HbA1c/glycohemoglobin determinations. J Int Fed Clin Chem. 1996;9(2):62-7.
17. Fiedler H, Zawta B. Fundamentals in laboratory medicine: diabetes mellitus and metabolic syndrome. Mannheim: Roche Diagnostics; 2004.
18. Shapiro R, McManus MJ, Zalut C, Bunn HF. Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem. 1980;255(7):3120-7. (Pubitemid 10089264)
19. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM, Sacks DB. Tests of glycemia in diabetes. Diabetes Care. 2004;27(7):1761-73 (Pubitemid 38857461)
20. Bunn HF. Nonenzymatic glycosylation of protein: relevance to diabetes. Am J Med. 1981;70(2):325-30. (Pubitemid 11146018)
21. Goldstein DE, Little RR, Wiedmeyer HM, England JD, McKenzie EM. Glycated hemoglobin: methodologies and clinical applications. Clin Chem. 1986;32(10 Suppl):B64-70.
22. Svendsen PA, Lauritzen T, Søegaard U, Nerup J. Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes. Diabetologia. 1982;23(5):403-5. (Pubitemid 12037379)
23. Cefalu WT, Wang ZQ, Bell-Farrow A, Kiger FD, Izlar C. Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clin Chem. 1994;40(7 Pt 1):1317-21. (Pubitemid 24205951)
24. Kilpatrick ES. Glycated haemoglobin in the year 2000. J Clin Pathol. 2000;53(5):335-9. (Pubitemid 30256899)
25. Tahara Y, Shima K. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care.1995;18(4):440-7.
26. Kilpatrick ES. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol. 2008;61(9):977-82.
27. Bloomgarden ZT. A1c: recommendations, debates, and questions. Diabetes Care. 2009;32(12):e141-7.
28. Aleyassine H. Glycosylation of hemoglobin S and hemoglobin C. Clin Chem. 1980;26(3):526-7.
29. Roberts WL, Frank EL, Moulton L, Papadea C, Noffsinger JK, Ou CN. Effects of nine hemoglobin variants on five glycohemoglobin methods. Clin Chem. 2000;46(4):569-72. (Pubitemid 30210733)
30. Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;47(2):153-63. (Pubitemid 32142912)
31. Tsai LY, Tsai SM, Lin MN, Liu SF. Effect of hemoglobin variants (Hb J, Hb G, and Hb E) on HbA1c values as measured by cationexchange HPLC (Diamat). Clin Chem. 2001;47(4):756-8.
32. Roberts WL, De BK, Brown D, Hanbury CM, Hoyer JD, John WG, Lambert TL, Lundell RB, Rohlfing C, Little RR. Effects of hemoglobin C and S traits on eight glycohemoglobin methods. Clin Chem. 2002;48(2):383-5. (Pubitemid 34107285)
33. Bissé E, Schauber C, Zorn N, Epting T, Eigel A, Van Dorsselaer A, Wieland H, Kister J, Kiger L. Hemoglobin Görwihl [alpha2beta(2)5(A2)Pro- >Ala], an electrophoretically silent variant with impaired glycation. Clin Chem. 2003;49(1):137-43. (Pubitemid 36078563)
34. Roberts WL, Safar-Pour S, De BK, Rohlfing CL, Weykamp CW, Little RR. Effects of hemoglobin C and S traits on glycohemoglobin measurements by eleven methods. Clin Chem. 2005;51(4):776-8. (Pubitemid 40463930)
35. Lee ST, Weykamp CW, Lee YW, Kim JW, Ki CS. Effects of 7 hemoglobin variants on the measurement of glycohemoglobin by 14 analytical methods. Clin Chem. 2007;53(12):2202-5. (Pubitemid 350197305)
36. Little RR, Rohlfing CL, Hanson S, Connolly S, Higgins T, Weykamp CW, D'Costa M, Luzzi V, Owen WE, Roberts WL. Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin Chem. 2008;54(8):1277-82.
37. Mongia SK, Little RR, Rohlfing CL, Hanson S, Roberts RF, Owen WE, D'Costa MA, Reyes CA, Luzzi VI, Roberts WL. Effects of hemoglobin C and S traits on the results of 14 commercial glycated hemoglobin assays. Am J Clin Pathol. 2008;130(1):136-40.
38. Sofronescu AG, Williams LM, Andrews DM, Zhu Y. Unexpected hemoglobin A1c results. Clin Chem. 2011;57(2):153-6.
39. Brooks AP, Metcalfe J, Day JL, Edwards MS. Iron deficiency and glycosylated haemoglobin A. Lancet. 1980;2(8186):141.
40. Davis RE, McCann VJ, Nicol DJ. Influence of iron-deficiency anaemia on the glycosylated haemoglobin level in a patient with diabetes mellitus. Med J Aust. 1983;1(1):40-1. (Pubitemid 13135876)
41. Tarim O, Küçükerdoǧan A, Günay U, Eralp O, Ercan I. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int. 1999;41(4):357-62. (Pubitemid 29376974)
42. El-Agouza I, Abu Shahla A, Sirdah M. The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosis. Clin Lab Haematol. 2002;24(5):285-9. (Pubitemid 35216312)
43. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 2004;112(3):126-8. (Pubitemid 39274157)
44. Koga M, Morita S, Saito H, Mukai M, Kasayama S. Association of erythrocyte indices with glycated haemoglobin in pre-menopausal women. Diabet Med. 2007;24(8):843-7. (Pubitemid 47093042)
45. Kilpatrick ES, Rigby AS, Atkin SL. The relationship between mean glucose and HbA1c in premenopausal women compared with males in the Diabetes Control and Complications Trial. Diabet Med. 2008;25(1):112-3.
46. Lum G. Artefactually low hemoglobin A1c in a patient with hemolytic anemia. Lab Med. 2010;41(5):267-70.
47. Herranz L, Grande C, Janez M, Pallardo F. Red blood cell autoantibodies with a shortened erythrocyte life span as a cause of lack of relation between glycosylated hemoglobin and mean blood glucose levels in a woman with type 1 diabetes. Diabetes Care. 1999;22(12):2085-6. (Pubitemid 30433995)
48. Liew CF, Cheah JS. Hereditary spherocytosis, a pitfall in the assessment of glycaemic control. Singapore Med J. 2003;44(2):94-7. (Pubitemid 36383499)
49. Kutter D, Thoma J. Hereditary spherocytosis and other hemolytic anomalies distort diabetic control by glycated hemoglobin. Clin Lab. 2006;52(9-10):477- 81. (Pubitemid 44649677)
50. Jiao Y, Okumiya T, Saibara T, Park K, Sasaki M. Abnormally decreased HbA1c can be assessed with erythrocyte creatine in patients with a shortened erythrocyte age. Diabetes Care. 1998;21(10):1732-5. (Pubitemid 28449816)
51. Weykamp CW, Penders TJ, Siebelder CW, Muskiet FA, van der Slik W. Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay. Clin Chem. 1993;39(1):138-42. (Pubitemid 23034974)
52. Virtue MA, Furne JK, Nuttall FQ, Levitt MD. Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration. Diabetes Care. 2004;27(4):931-5. (Pubitemid 38420217)
53. Mosca A, Paleari R, Dalfrà MG, Di Cianni G, Cuccuru I, Pellegrini G, Malloggi L, Bonomo M, Granata S, Ceriotti F, Castiglioni MT, Songini M, Tocco G, Masin M, Plebani M, Lapolla A. Reference intervals for hemoglobin a1c in pregnant women: data from an Italian multicenter study. Clin Chem. 2006;52(6):1138-43. (Pubitemid 43794427)
54. Radder JK, van Roosmalen J. HbA1c in healthy, pregnant women. Neth J Med. 2005;63(7):256-9.
55. Nielsen LR, Ekbom P, Damm P, Glümer C, Frandsen MM, Jensen DM, Mathiesen ER. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care. 2004;27(5):1200-1. (Pubitemid 38579790)
56. Hashimoto K, Noguchi S, Morimoto Y, Hamada S, Wasada K, Imai S, Murata Y, Kasayama S, Koga M. A1c but not serum glycated albumin is elevated in late pregnancy owing to iron deficiency. Diabetes Care. 2008;31(10):1945-8.
57. Hartland AJ, Smith JM, Clark PM, Webber J, Chowdhury T, Dunne F. Establishing trimester- and ethnic group-related reference ranges for fructosamine and HbA1c in non-diabetic pregnant women. Ann Clin Biochem. 1999;36(Pt 2):235-7. (Pubitemid 29116937)
58. Herranz L, Saez-de-Ibarra L, Grande C, Pallardo LF. Non-glycemic- dependent reduction of late pregnancy A1c levels in women with type 1 diabetes. Diabetes Care. 2007;30(6):1579-80. (Pubitemid 46871175)
59. O'Kane MJ, Lynch PL, Moles KW, Magee SE. Determination of a diabetes control and complications trial-aligned HbA(1c) reference range in pregnancy. Clin Chim Acta. 2001;311(2):157-9. (Pubitemid 32889701)
60. Ulf S, Ragnar H, Arne WP, Johnny L. Do high blood glucose peaks contribute to higher HbA1c? Results from repeated continuous glucose measurements in children. World J Pediatr. 2008;4(3):215-21.
61. Derr R, Garrett E, Stacy GA, Saudek CD. Is HbA(1c) affected by glycemic instability? Diabetes Care. 2003;26(10):2728-33.
62. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR; ADAG Study Group. HbA1(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study. Diabetologia. 2011;54(1):69-72.
63. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA. 2006;295(14):1707-8.
64. Saudek CD, Derr RL, Kalyani RR. Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA. 2006;295(14):1688-97.
65. Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes Care. 2008;31 Suppl 2:S150-4.
66. Kuenen JC, Borg R, Kuik DJ, Zheng H, Schoenfeld D, Diamant M, Nathan DM, Heine RJ; ADAG Study Group. Does glucose variability influence the relationship between mean plasma glucose and HbA1c levels in type 1 and type 2 diabetic patients? Diabetes Care. 2011;34(8):1843-7.
67. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405-12. (Pubitemid 30609442)
68. Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes. 1995;44(8):968-83.
69. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995;18(2):258-68.
70. Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia. 2008;51(1):183-90. (Pubitemid 50002199)
71. Rohlfing C, Wiedmeyer HM, Little R, Grotz VL, Tennill A, England J, Madsen R, Goldstein D. Biological variation of glycohemoglobin. Clin Chem. 2002;48(7):1116-8. (Pubitemid 34680915)
72. Fraser CG. Biological variation: from principles to practice. Washington DC: American Association of Clinical Chemistry Press; 2001.
73. Diekman MJ, Salden HJ, DeVries JH. A patient with hyperglycaemia and normal HbA Ic due to impaired glycation. Neth J Med. 2007;65(10):395-7. (Pubitemid 350162325)
74. Phillipov G, Phillips PJ. Components of total measurement error for hemoglobin A(1c) determination. Clin Chem. 2001;47(10):1851-3. (Pubitemid 32881201)
75. McCarter RJ, Hempe JM, Chalew SA. Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial. Diabetes Care. 2006;29(2):352-5. (Pubitemid 44106517)
76. McCarter RJ, Hempe JM, Gomez R, Chalew SA. Biological variation in HbA1c predicts risk of retinopathy and nephropathy in type 1 diabetes. Diabetes Care. 2004;27(6):1259-64. (Pubitemid 38679967)
77. Hempe JM, Gomez R, McCarter RJ Jr, Chalew SA. High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control. J Diabetes Complications. 2002;16(5):313-20.
78. Yudkin JS, Forrest RD, Jackson CA, Ryle AJ, Davie S, Gould BJ. Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia. Diabetologia. 1990;33(4):208-15. (Pubitemid 20136237)
79. Kalish GM, Barrett-Connor E, Laughlin GA, Gulanski BI; Postmenopausal Estrogen/Progestin Intervention Trial. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab. 2003;88(4):1646-52. (Pubitemid 36623382)
80. Araneta MR, Barrett-Connor E. Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obes Res. 2005;13(8):1458-65.
81. Snieder H, Sawtell PA, Ross L, Walker J, Spector TD, Leslie RD. HbA(1c) levels are genetically determined even in type 1 diabetes: evidence from healthy and diabetic twins. Diabetes. 2001;50(12):2858-63. (Pubitemid 33733139)
82. Cohen RM, Snieder H, Lindsell CJ, Beyan H, Hawa MI, Blinko S, Edwards R, Spector TD, Leslie RD. Evidence for independent heritability of the glycation gap (glycosylation gap) fraction of HbA1c in nondiabetic twins. Diabetes Care. 2006;29(8):1739-43. (Pubitemid 44156623)
83. Gallegos-Macias AR, Macias SR, Kaufman E, Skipper B, Kalishman N. Relationship between glycemic control, ethnicity and socioeconomic status in Hispanic and white non-Hispanic youths with type 1 diabetes mellitus. Pediatr Diabetes. 2003;4(1):19-23. (Pubitemid 36621663)
84. Eldeirawi K, Lipton RB. Predictors of hemoglobin A1c in a national sample of nondiabetic children: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol. 2003;157(7):624-32. (Pubitemid 36368533)
85. Maney M, Tseng CL, Safford MM, Miller DR, Pogach LM. Impact of self-reported patient characteristics upon assessment of glycemic control in the Veterans Health Administration. Diabetes Care. 2007;30(2):245-51. (Pubitemid 46198326)
86. Herman WH. Do race and ethnicity impact hemoglobin A1c independent of glycemia? J Diabetes Sci Technol. 2009;3(4):656-60.
87. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E; Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care. 2007;30(10):2453-7. (Pubitemid 47547771)
88. Herman WH, Dungan KM, Wolffenbuttel BH, Buse JB, Fahrbach JL, Jiang H, Martin S. Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetes. J Clin Endocrinol Metab. 2009;94(5):1689-94.
89. Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, Narayan KM, Koch DD, Phillips LS. Glucoseindependent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152(12):770-7.
90. Selvin E, Steffes MW, Ballantyne CM, Hoogeveen RC, Coresh J, Brancati FL. Racial differences in glycemic markers: a cross-sectional analysis of community-based data. Ann Intern Med. 2011;154(5):303-9.
91. Meigs JB, Panhuysen CI, Myers RH, Wilson PW, Cupples LA. A genome-wide scan for loci linked to plasma levels of glucose and HbA(1c) in a community-based sample of Caucasian pedigrees: The Framingham Offspring Study. Diabetes. 2002;51(3):833-40. (Pubitemid 34760197)
92. Simonis-Bik AM, Eekhoff EM, Diamant M, Boomsma DI, Heine RJ, Dekker JM, Willemsen G, van Leeuwen M, de Geus EJ. The heritability of HbA1c and fasting blood glucose in different measurement settings. Twin Res Hum Genet. 2008;11(6):597-602.
93. Dubrey SW, Reaveley DR, Seed M, Lane DA, Ireland H, O'Donnell M, O'Connor B, Noble MI, Leslie RD. Risk factors for cardiovascular disease in IDDM. A study of identical twins. Diabetes. 1994;43(6):831-5. (Pubitemid 24166361)
94. Borch-Johnsen K, Nørgaard K, Hommel E, Mathiesen ER, Jensen JS, Deckert T, Parving HH. Is diabetic nephropathy an inherited complication? Kidney Int. 1992;41(4):719-22.
95. Hietala K, Forsblom C, Summanen P, Groop PH; FinnDiane Study Group. Heritability of proliferative diabetic retinopathy. Diabetes. 2008;57(8):2176-80.
96. Avignon A, Radauceanu A, Monnier L. Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care. 1997;20(12):1822-6. (Pubitemid 27522889)
97. Bonora E, Calcaterra F, Lombardi S, Bonfante N, Formentini G, Bonadonna RC, Muggeo M. Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control. Diabetes Care. 2001;24(12):2023-9. (Pubitemid 33716515)
98. El-Kebbi IM, Ziemer DC, Cook CB, Gallina DL, Barnes CS, Phillips LS. Utility of casual postprandial glucose levels in type 2 diabetes management. Diabetes Care. 2004;27(2):335-9. (Pubitemid 38174054)
99. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care. 2002;25(2):275-8. (Pubitemid 41079621)
100. Prendergast C, Smyth O, Murray F, Cunningham SK, McKenna TJ. The relationship of blood glucose and haemoglobin A1 levels in diabetic subjects. Ir J Med Sci. 1994;163(5):233-5. (Pubitemid 24178611)
101. Bastyr EJ 3rd, Stuart CA, Brodows RG, Schwartz S, Graf CJ, Zagar A, Robertson KE; IOEZ Study Group. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbA1c. Diabetes Care. 2000;23(9):1236-41.
102. Levetan CS, Jeng LM, Thornton KR, Want L, Ratner RE. When do glucose values best correlate with hemoglobin A1c? Diabetes. 2001;50(2 Suppl):A124.
103. Kovatchev BP, Cox DJ, Straume M, Farhy LS. Association of self-monitoring blood glucose profiles with glycosylated hemoglobin in patients with insulin-dependent diabetes. Methods Enzymol. 2000;321:410-7. (Pubitemid 30457557)
104. Peterson CM, Jones RL, Dupuis A, Levine BS, Bernstein R, O'Shea M. Feasibility of improved blood glucose control in patients with insulin-dependent diabetes mellitus. Diabetes Care. 1979;2(4):329-35. (Pubitemid 11190664)
105. Ditzel J, Kjaergaard JJ. Haemoglobin AIc concentrations after initial insulin treatment for newly discovered diabetes. Br Med J. 1978;1(6115):741-2. (Pubitemid 8318317)
106. American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care. 2011;34 Suppl 1:S11-61.
107. Makris K, Spanou L, Rambaouni-Antoneli A, Koniari K, Drakopoulos I, Rizos D, Haliassos A. Relationship between mean blood glucose and glycated haemoglobin in type 2 diabetic patients. Diabet Med. 2008;25(2):174-8. (Pubitemid 351293410)
108. Nathan DM, Turgeon H, Regan S. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia. 2007;50(11):2239-44. (Pubitemid 47512407)
109. Murata GH, Hoffman RM, Duckworth WC, Wendel CS, Shah JH; Diabetes Outcomes in Veterans Study. Contributions of weekly mean blood glucose values to hemoglobin A1c in insulin-treated type 2 diabetes: the diabetes outcomes in veterans study (DOVES). Am J Med Sci. 2004;327(6):319-23. (Pubitemid 38780175)
110. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ; A1c-Derived Average Glucose Study Group. Translating the A1c assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-8.
111. Diabetes Research in Children Network (DirecNet) Study Group, Wilson DM, Kollman. Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors. Diabetes Care. 2008;31(3):381-5.
112. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Wilson DM, Xing D, Beck RW, Block J, Bode B, Fox LA, Hirsch I, Kollman C, Laffel L, Ruedy KJ, Steffes M, Tamborlane WV. Hemoglobin A1c and mean glucose in patients with type 1 diabetes: analysis of data from the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Care. 2011;34(3):540-4.
113. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR; ADAG Study Group. Associations between features of glucose exposure and A1C: the A1CDerived Average Glucose (ADAG) study. Diabetes. 2010;59(7):1585-90.
114. Borg R, Kuenen JC, Carstensen B, Zheng H, Nathan DM, Heine RJ, Nerup J, Borch-Johnsen K, Witte DR; ADAG Study Group. Reallife glycaemic profiles in non-diabetic individuals with low fasting glucose and normal HbA1c: the A1c-Derived Average Glucose (ADAG) study. Diabetologia. 2010;53(8):1608-11.
115. Weykamp C, John WG, Mosca A. A review of the challenge in measuring Hemoglobin A1c. J Diabetes Sci Technol. 2009;3(3):439-45.
116. Weykamp C, John WG, Mosca A, Hoshino T, Little R, Jeppsson JO, Goodall I, Miedema K, Myers G, Reinauer H, Sacks DB, Slingerland R, Siebelder C. The IFCC reference measurement system for HbA1c: a 6-year progress report. Clin Chem. 2008;54(2):240-8. (Pubitemid 351302616)
117. Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem. 2010;56(1):44-52.
118. Chang A, Frank J, Knaebel J, Fullam J, Pardo S, Simmons DA. Evaluation of an over-the-counter glycated hemoglobin (A1c) test kit. J Diabetes Sci Technol. 2010;4(6):1495-503.
119. Dungan K, Chapman J, Braithwaite SS, Buse J. Glucose measurement: confounding issues in setting targets for inpatient management. Diabetes Care. 2007;30(2):403-9. (Pubitemid 46198356)
120. Lyon ME, DuBois JA, Fick GH, Lyon AW. Estimates of total analytical error in consumer and hospital glucose meters contributed by hematocrit, maltose, and ascorbate. J Diabetes Sci Technol. 2010;4(6):1479-94.
121. Seufert J. Addressing glycaemic variation. Br J Diabetes Vasc Dis. 2011;11(Suppl 1):S2-5.
122. Vaddiraju S, Burgess DJ, Tomazos I, Jain FC, Papadimitrakopoulos F. Technologies for continuous glucose monitoring: current problems and future promises. J Diabetes Sci Technol. 2010;4(6):1540-62.
123. Enns RH. It's a nonlinear world. New York: Springer; 2011.